![Zhi Dong Pan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Zhi Dong Pan
Directeur/Membre du Conseil chez MabPlex International Co., Ltd.
Profil
Zhi Dong Pan is currently a Director at MabPlex International Co., Ltd.
He previously served as a Member-Supervisory Board at Dalian Huarui Heavy Industry Group Co., Ltd.
He earned a doctorate degree from Dalian Maritime University in 2017.
Postes actifs de Zhi Dong Pan
Sociétés | Poste | Début |
---|---|---|
MabPlex International Co., Ltd.
![]() MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Directeur/Membre du Conseil | 01/03/2020 |
Anciens postes connus de Zhi Dong Pan
Sociétés | Poste | Fin |
---|---|---|
DALIAN HUARUI HEAVY INDUSTRY GROUP CO., LTD. | Directeur/Membre du Conseil | - |
Formation de Zhi Dong Pan
Dalian Maritime University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
DALIAN HUARUI HEAVY INDUSTRY GROUP CO., LTD. | Non-Energy Minerals |
Entreprise privées | 1 |
---|---|
MabPlex International Co., Ltd.
![]() MabPlex International Co., Ltd. Pharmaceuticals: MajorHealth Technology MabPlex International Co., Ltd. engages in the provision of contract development and manufacturing organization (CDMO) services in the biopharmaceutical field. It provides CDMO services for monoclonal antibodies, double antibodies, polyclonal antibodies, fusion proteins, antibody-drug conjugates, recombinant vaccines, recombinant proteins, and other biological drugs; and cell culture medium. The company was founded by Jan Min Fang on June 25, 2013 and is headquartered in Yantai, China. | Health Technology |